- Home
- Â /Â Avrobio
Avrobio
Stock Price
$1.4
2024-06-21
Market Capitalization
$5.2 M
2024-06-21
Avrobio Summary
Company Summary
- Overview
- Gene therapy has the potential to deliver dramatic disease modifying effects and potentially life-long cures from a single infusion of genetically-modified cells.
- Type
- Public
- Status
- Active
- HQ
- Cambridge, MA, US | view all locations
- Website
- http://www.avrobio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Erik Ostrowski, Chief Financial Officer
Azadeh Golipour, Chief Technology Officer
Deanna Petersen, Chief Business Officer
LocationsView all
1 location detected
Cambridge, MAÂ HQ
United States
One Kendall Square Building 300 Suite 201
Avrobio Financials
Summary Financials
- Net income (Q1, 2025)
- ($15.9M)
- Cash (Q1, 2025)
- $306.2M
- EBIT (Q1, 2025)
- ($18.3M)
- Enterprise value
- ($298.8M)